Blog Posts Examine National Action Plan For Combating Multidrug-Resistant TB

RESULTS blog: Launch of White House Action Plan on Drug Resistant TB!
David Bryden, TB advocacy officer at RESULTS, discusses the launch of the White House’s National Action Plan for Combating Multidrug-Resistant Tuberculosis. “The President’s Action Plan raises hopes and expectations around the world, but a proposal for a funding reduction, in his February 9 budget proposal to Congress, would betray these hopes and could harm the exciting and growing global momentum we have seen on TB. He should use his last budget to jump start progress on TB,” Bryden writes (1/12).

Center for Global Health Policy’s “Science Speaks”: USAID announces new partnerships to combat MDR-TB at White House plan launch
Rabita Aziz, policy research coordinator for the Center for Global Health Policy, discusses the launch of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, as well as USAID’s announcement of expanded partnerships with Janssen, maker of the TB drug bedaquiline, and Cepheid, manufacturer of a rapid diagnostic test for MDR-TB. Aziz notes that TB advocates suggest the price of bedaquiline is high and there is a need for the U.S. to encourage donors to increase contributions to efforts to end the disease (1/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.